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Pharmacological inhibitors of cysteine proteases have provided
useful insights into the regulation of calpain activity in
erythrocytes. However, the precise biological function of calpain
activity in erythrocytes remains poorly understood. Erythrocytes
express calpain-1, an isoform regulated by calpastatin, the
endogenous inhibitor of calpains. In the present study, we
investigated the function of calpain-1 in mature erythrocytes using
our calpain-1-null [KO (knockout)] mouse model. The calpain-1
gene deletion results in improved erythrocyte deformability
without any measurable effect on erythrocyte lifespan in vivo.
The calcium-induced sphero-echinocyte shape transition is
compromised in the KO erythrocytes. Erythrocyte membrane
proteins ankyrin, band 3, protein 4.1R, adducin and dematin are
degraded in the calcium-loaded normal erythrocytes but not in
the KO erythrocytes. In contrast, the integrity of spectrin and
its state of phosphorylation are not affected in the calcium-
loaded erythrocytes of either genotype. To assess the functional
consequences of attenuated cytoskeletal remodelling in the KO
erythrocytes, the activity of major membrane transporters was
measured. The activity of the K+–Cl− co-transporter and the
Gardos channel was significantly reduced in the KO erythrocytes.
Similarly, the basal activity of the calcium pump was reduced
in the absence of calmodulin in the KO erythrocyte membrane.
Interestingly, the calmodulin-stimulated calcium pump activity
was significantly elevated in the KO erythrocytes, implying a
wider range of pump regulation by calcium and calmodulin. Taken
together, and with the atomic force microscopy of the skeletal
network, the results of the present study provide the first evidence
for the physiological function of calpain-1 in erythrocytes with
therapeutic implications for calcium imbalance pathologies such
as sickle cell disease.
Key words: calcium pump, calpain-1, deformability, erythrocyte,
K+–Cl− co-transporter (KCC1), spectrin.
INTRODUCTION
Calpains are widely expressed cysteine proteases activated by
calcium at neutral pH. They play functional roles in numerous
physiological processes, including cytoskeletal reorganization,
cell motility, apoptosis, neuronal biogenesis and haemostasis
[1,2]. Genome sequencing has identified at least 14 members
of the calpain superfamily. Among them, calpain-1 and calpain-2,
also designated as μ-calpain and m-calpain respectively, remain
the two most well-characterized members of the calpain
family of proteases. Calpain-1, encoded by the Capn1 gene,
requires lower calcium concentration for activation, whereas
calpain-2, encoded by the Capn2 gene, is activated at higher
concentrations of calcium [1]. A delicate balance exists in vivo
between calpain-1, calpain-2 and calpastatin, the endogenous
inhibitor of both calpains, providing a regulatory mechanism for
calcium-mediated activation of calpain activity. Both calpain-
1 and calpain-2 are expressed in varying levels in most
mammalian tissues [3]. In general, the expression of calpain-1
dominates in the haematopoietic compartment, whereas calpain-2
expression is more prominent in the nonhaemopoietic cells. Since
pharmacological inhibitors generally cannot distinguish between
calpain-1 and calpain-2 activity, and may exert off-target effects,
gene targeting has been employed to tease out the specific function
of calpains in vivo.
The erythrocyte has served as a useful model system to study
the physiological role of calpain activity in mammalian cells.
The rationale for this approach was based on the expectation that
identification of calpain-1 substrates in erythrocytes may provide
leads for calpain-1 function in other cell types, since homologues
of erythrocyte proteins exist in many non-erythroid cells. The
mature erythrocyte offers a unique model system where calpain-1
function can be evaluated in the absence of calpain-2 activity [3,4].
Moreover, mature erythrocytes lack any internal calcium storage
organelles, thus permitting assessment of calpain-1 function
mostly at the plasma membrane. For example, previous studies
have shown calpain-mediated cleavage of membrane-bound
Ca2 + -ATPase, also known as calcium pump or PMCA (plasma-
membrane Ca2 + -ATPase), which regulates calcium transport
in erythrocytes [5,6]. Similarly, calpain-mediated proteolysis
of haemoglobin is believed to provide a mechanism for the
autocatalytic inactivation of calpain activity and formation of
Heinz bodies. Activation of calpain is also required for the regu-
lation of erythrocyte membrane fusion events triggered by the
influx of calcium [7]. Moreover, evidence suggests that calpain
activity plays a role in the regulation of protein phosphorylation
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of erythrocyte membrane proteins such as protein 4.1R [8]. Since
phosphorylation of protein 4.1R modulates its interaction with
spectrin, actin and the plasma membrane, it was proposed that
calpain-mediated proteolysis of PKC (protein kinase C), which
phosphorylates protein 4.1R, is required for erythrocyte survival
during circulatory stress in vivo [8].
The functional role of calpain activity in erythrocytes has
been traditionally investigated by employing the pharmacological
inhibitors of cysteine proteases [8]. For example, the role
of calpain activity in the regulation of erythrocyte PKC was
established by resealing the calpain inhibitors leupeptin and
E-64 in mature erythrocytes [8]. Although this approach has
been successful in inhibiting calpain activity in erythrocytes,
the possibility of off-target effects by these synthetic inhibitors
cannot be ruled out. A case in point is calpeptin, a known
calpain inhibitor that also inhibits the calpeptin-sensitive protein-
tyrosine phosphatase acting upstream of the RhoA GTPase
[9]. To overcome these limitations, we used calpain-1-null
mice to investigate the effect of calpain-1 loss in mature
erythrocytes in the absence of compensation by either calpain-2
or any other cysteine protease. We provide the first evidence
that calpain-1 negatively regulates erythrocyte deformability
and filterability without any discernible effect on erythrocyte
lifespan under normal conditions. Our findings also reveal
some unexpected consequences of calpain-1 loss on erythrocyte
shape, activity of transporters and phosphorylation of membrane
proteins. Together, these results raise the possibility that selective
pharmacological inhibition of calpain-1 may offer new therapeutic
options for erythrocyte pathologies with aberrant calcium
homoeostasis, such as sickle cell disease.
EXPERIMENTAL
Antibodies and reagents
Antibodies against spectrin, ankyrin, band 3, protein 4.1R,
dematin and p55 were generated in our laboratory. A monoclonal
antibody against calpain was purchased from NOVACASTRA,
and a monoclonal antibody (5F10) against the erythrocyte calcium
pump (PMCA) was a gift from Dr Emanuel Strehler (Mayo Clinic,
Rochester, MN, U.S.A.). The calcium ionophore A23187 was
purchased from Calbiochem. [32P]Pi was obtained from DuPont
New England Nuclear. PMA, DMSO, dibutyryl-cAMP and other
common reagents were purchased from Sigma.
Haematological analysis
Mice were anaesthetized by inhalation of 3% isoflurane under
an approved Institutional Animal Care and Use Committee
protocol. Blood from 3–4-month-old WT (wild-type) and calpain-
1 (Capn1)-null mice was collected in either heparin- or EDTA-
containing tubes. Blood smears were stained with Wright-
Giemsa (Sigma), and reticulocytes were counted after staining
with New Methylene Blue (manual count). Erythrocyte and
reticulocyte numbers were determined using an automated
haematological analyser (ADVIA 120; Multispecies software;
Siemens Diagnostic Solutions).
Erythrocyte deformability
Blood was collected into acid citrate dextrose anticoagulant
and used within 24 h. Blood (∼850 μl) was drawn from mice
via the inferior vena cava while anaesthetized using isoflurane,
transferred to 1.5 ml tubes, and spun at 1000 g for 5 min. After
removing plasma and buffy coat by aspiration, erythrocytes
were washed with PBS and spun again at 1000 g for 5 min.
Erythrocytes were then transferred to 15 ml tubes and washed
twice using PBS and centrifugation at 1500 g for 5 min.
Erythrocytes were suspended in 1.0 ml of calcium-free Tyrode’s
buffer (10 mM Hepes, 12 mM NaHCO3, pH 7.5, 137 mM NaCl,
2.5 mM KCl, 5 mM glucose and 0.1% BSA), and counted using
a haemocytometer. Samples were normalized to 8×106 cells/mm3
with Tyrode’s buffer. Experimental samples were prepared using
200 μl of erythrocyte suspension and 800 μl of Tyrode’s buffer
with A23187 added to a final concentration of 1.0 μM, with and
without 50 μM calcium. The erythrocytes were incubated at 37 ◦C
for 20 min, spun down at 1000 g for 5 min, and suspended in
100 μl of Tyrode’s buffer.
Erythrocyte deformability was assessed using a laser diffraction
Ektacytometer with a thin micro-channel as the shearing geometry
(RheoScan-D300; RheoMeditech) [10,11]. The erythrocyte
suspension (6 μl) of each genotype was mixed with the PBS-
PVP (polyvinylpyrrolidone) aliquot (600 μl volume). The
PBS-PVP solution was provided as part of the commercial kit with
the RheoScan-D300 instrument. The erythrocyte mixture (500 μl)
was transferred to the cartridge and tested using RheoScan-
D300. Each sample was tested at least three times each in this
manner. The RheoScan-D300 measures the length and width
of the erythrocytes at 16 shear stress levels from 20 to 0.5 Pa
using a CCD (charge-coupled-device) camera and computer to
measure the EI (elongation index). The EI is calculated as EI =
(L − W)/(L + W), and the results are given as means +− S.D. in the
Figures.
Erythrocyte filterability
Analysis of the rate of filtration of an erythrocyte suspension
through a highly uniform nickel mesh filter was conducted by
a gravity-based vertical tube method as described in [12]. This
method measures the rate of passage of erythrocytes through the
filter as a function of hydrostatic pressure (Tsukusa Sokken). The
pore diameter of the nickel mesh used in the present study was
4.6 μm. From a height (pressure)–time curve obtained during the
filtration analysis, a pressure–flow rate relationship can be de-
termined. The filtration was started at a pressure of 150 mmH2O,
and the percentage of the flow rate (ml/min) of the erythrocyte
suspension (0.1% haematocrit) in Hepes buffer (96 mM KCl,
64 mM NaCl, 10 mM glucose, 1.0 mM MgCl2 and 16 mM Hepes,
pH 7.5) relative to that of the aqueous suspending medium at
100 mmH2O was taken as the index of erythrocyte filterability.
Erythrocyte osmotic fragility
Osmotic fragility assay was performed on freshly obtained
erythrocytes from 4–6-month-old WT and calpain-1-null mice
in the presence of heparin as an anticoagulant. Blood was
washed three times with PBS and resuspended in PBS at 20%
haematocrit, followed by incubation with either 1.0 μM of the
calcium ionophore A23187, or 1.0 μM A23187 plus 100 μM
CaCl2 for 15 min at 37 ◦C. Erythrocytes were washed twice with
the ice-cold salt solution (154 mM NaCl, 9.5 mM Na2HPO4 and
1.5 mM NaH2PO4, pH 7.4; 100% salt solution) to terminate
calcium loading. Erythrocyte lysis was monitored by the release
of haemoglobin into the supernatant upon incubation of cells
with graded salt concentrations (100–1%) for 30 min at room
temperature (23 ◦C). Erythrocyte suspensions were centrifuged
and the absorbance of the supernatant was recorded at 540 nm.
Each sample in water was taken as 100% erythrocyte lysis, and
readings of the same sample in various osmolarity solutions were
normalized.
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Erythrocyte lifespan
The in vivo lifespan of erythrocytes was determined as described
previously [13]. Briefly, adult mice were injected with NHS
(N-hydroxysuccinimide)–biotin through a tail-vein injection.
Blood was drawn in PBS-G (PBS plus 10 mM glucose) on specific
days, and washed erythrocytes were incubated with avidin–
FITC at 37 ◦C for 1 h. Erythrocytes were washed with PBS-G,
and the percentage of labelled cells was determined by flow
cytometry. Erythrocyte labelling was greater than 95%, and in
most experiments, the labelling was close to 99%. The same gate
was used for both WT and calpain-1-null erythrocytes.
Erythrocyte shape change analysis
The erythrocyte shape change assay was performed essentially
as described previously [14]. Briefly, blood from six WT and
six calpain-1-null mice was drawn into a syringe containing
3.8% trisodium citrate (1:10, v/v). Blood pooled from each
genotype was centrifuged at 100 g for 10 min. The erythrocyte
pellet was washed three times and resuspended in HBSS (Hanks
buffered salt solution, pH 7.3) containing 0.1% BSA but devoid
of calcium. A final spin of 800 g for 10 min was performed
to pack the erythrocytes, and the cells were resuspended in
medium as described above to 1% haematocrit. Each sample
was incubated at 37 ◦C without calcium, and with 50 μM or
1.0 mM CaCl2 in the presence of 1.5 μM calcium ionophore
A23187 for up to 60 min. Erythrocyte samples were then placed
on to a siliconized glass slide, and visualized by DIC (differential
interference contrast) microscopy using a 100× objective on a
Nikon Eclipse TE2000-E inverted microscope. A total of ten
random fields of acquired images were analysed for quantification
of erythrocyte morphology at different time intervals. The images
are representative of three independent experiments.
SDS/PAGE and Western blotting
Erythrocyte membrane proteins from ghosts were separated on
8% polyacrylamide gels and stained with Coomassie Blue
(Laemmli gel system). Proteins were transferred on to a
nitrocellulose membrane (Bio-Rad Laboratories), blocked with
5% non-fat dried skimmed milk powder in Tris-buffered saline
(BDH Chemicals) containing 0.1% Tween 20, and analysed with
the respective antibodies. Enhanced chemiluminescence detection
was performed using the SuperSignal West Pico kit (Pierce).
Calpain-1 activation and erythrocyte membrane proteins
Blood was collected from WT and calpain-1-null mice in heparin
tubes. Erythrocytes were washed with PBS to remove the buffy
coat, and resuspended in calcium-free Tyrode’s buffer. For
activation of calpain-1, erythrocytes were incubated with 1.0 μM
calcium ionophore A23187 for 3.0 min at 37 ◦C followed by
the addition of various concentrations of CaCl2. Erythrocytes
were further incubated for 10–20 min at 37 ◦C, and incubation
was terminated by cell lysis in 10 vol. of ice-cold lysis buffer
(5 mM sodium phosphate buffer, pH 8.0, 1.0 mM EDTA and
1.0 mM PMSF). Erythrocyte ghosts were prepared, resuspended
in SDS sample buffer, and analysed by SDS/PAGE and Western
blotting.
Radioactive labelling of erythrocyte membrane proteins
Freshly harvested erythrocytes were resuspended at 20%
haematocrit in solution A (145 mM NaCl, 5.0 mM KCl, 10 mM
Hepes, pH 7.4, and 0.1 mM Na2HPO4), and incubated at 37 ◦C
with 0.4 mCi/ml of [32P]Pi for 2 h to label the intracellular
ATP pool. Aliquots (250 μl) of cells were then treated with
either 2.0 mM dibutyryl-cAMP or 1.0 μM PMA, or 1.0 μM
calcium ionophore A23187 plus 500 μM of CaCl2 at 37 ◦C for
the indicated time intervals. Erythrocytes were washed once with
ice-cold solution A, and then immediately lysed with 10 vol.
of ice-cold lysis buffer. Erythrocyte ghosts were washed twice
with lysis buffer, solubilized in SDS sample buffer, and
radiolabelled proteins were visualized by SDS/PAGE (8% gels)
and autoradiography.
Erythrocyte K+–Cl− co-transport activity
K+–Cl− co-transport and ion content
Heparinized blood collected from the mouse inferior vena cava
was processed for measurement of red cell indices using an
ADVIA 120 haemoanalyser (Siemens Diagnostic Solutions).
Plasma and buffy coat were removed after passing through cotton,
and cells were centrifuged at 1350 g for 4 min at 4 ◦C. The red cell
pellet was washed four times with an ice-cold CWS (choline wash
solution) containing 172 mM choline chloride, 1.0 mM MgCl2
and 10 mM Tris/Mops, pH 7.4, at 4 ◦C as described previously
[15]. An aliquot of cells was then suspended at 50% volume
with Mg2 + -free CWS, and determinations of haematocrit and cell
Mg2 + (1:50 dilution) were performed. Erythrocyte Mg2 + content
was determined by atomic absorption spectrophotometry with
standards made in double distilled water. The activity of KCC1
(K+–Cl− co-transporter) was calculated as the difference between
K+ efflux in hypotonic NaCl (100 mM), isotonic NaCl (160 mM),
and hypotonic sodium sulfamate (100 mM) media [16]. Fluxes
were measured between 5 and 35 min at 37 ◦C, and the flux was
estimated from the slope of the time course curve. The maximal
rates of KCC1 activity was calculated from the difference between
the volume-sensitive fraction and the Cl−-dependent K+ flux, and
expressed as mmol/1013 cells per h.
Gardos channel activity
Freshly washed erythrocytes were suspended at 2% haematocrit
in isotonic influx media containing 165 mM NaCl, 2.0 mM
KCl, 0.15 mM MgCl2, 1.0 mM ouabain and 10 mM Tris/Mops,
pH 7.4, at 22 ◦C, 10 μM bumetanide and 10 μCi/ml 86Rb in
the presence or absence of 50 nM charybdotoxin, a specific
blocker of the Gardos channel. Free Ca2 + in the influx
media was buffered to 7.0 μM with 1.0 mM citrate buffer as
described previously [15]. At zero time, calcium ionophore
A23187 (5 μM) was added and aliquots were removed at 0.33,
2 and 5 min and immediately spun down through 0.8 ml of
unlabelled medium containing 5.0 mM EGTA buffer and an
underlying cushion of n-butyl phthalate. Supernatants were
aspirated, and the tube tip containing the radioactive cell
pellet was cut off. The erythrocyte-associated radioactivity was
measured in a gamma counter (model 41600 HE; Isomedic
ICN-MP Biomedicals). The K+ uptake was linear up to 5 min,
and fluxes were calculated from the slope of the linear regression
as described previously [15].
Erythrocyte calcium pump activity
Isolation of erythrocyte membranes
Mouse erythrocyte membranes were isolated from freshly
collected blood as described previously [17]. Briefly, blood
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was centrifuged at 1942 g for 15 min, plasma and buffy
coat were aspirated off, and erythrocytes were lysed in a
hypotonic buffer containing 10 mM Tris/HCl, pH 6.7, and 0.5 mM
EDTA. Membranes (ghosts) were centrifuged several times at
10000 rev./min for 20 min in a JA20 rotor to remove haemoglobin,
and washed using a hypertonic buffer containing 10 mM Hepes,
pH 7.2, 120 mM KCl, 0.5 mM MgCl2 and 50 μM CaCl2 until
free of haemoglobin. Protein concentration was determined using
a BCA (bicinchoninic acid) kit (Pierce). Ghosts were divided into
small aliquots and frozen at − 80 ◦C until further analysis.
Measurement of PMCA activity
Erythrocyte membranes isolated from the WT and calpain-1-null
mice were assayed for PMCA activity in a 96-well plate using the
Malachite Green colorimetric assay [18]. Activity of PMCA was
determined by measuring the release of Pi by calcium-dependent
ATP hydrolysis. Each well, in a final volume of 100 μl, contained
25 mM Tris/HCl, pH 7.4, 50 mM KCl, 1.0 mM MgCl2, 0.1 mM
ouabain, 4.0 μg/ml oligomycin, 200 μM EGTA and CaCl2 to
give the desired final free Ca2 + concentration (ranging from 1–
10 μM). The final free Ca2 + concentration was calculated using
the software calcium.com, which calculates multiple equilibria
between all ligands in solution. The PMCA activity, measured in
the presence of calcium without CaM (calmodulin), is referred
to as the ‘basal’ activity, and that measured in the presence of
calcium and CaM (340 nM) as ‘CaM-stimulated’ activity. After
a 5 min pre-incubation of PMCA with the assay components,
the reaction was started by the addition of ATP (1.0 mM final
concentration), continued for 30 min at 37 ◦C, and stopped by
the addition of Malachite Green dye. The contents were made
acidic by the addition of 19.5% H2SO4, incubated for 45 min,
and colour measured at 650 nm in a plate reader. The PMCA
activity was defined as the calcium-activated ATP hydrolysis and
expressed as nanomoles of Pi liberated per mg of protein per min
based on the values from a standard curve of the absorbance at
various concentrations of free Pi.
AFM (atomic force microscopy)
Erythrocyte attachment on the surface-modified glass coverslips,
cytoskeleton exposure, AFM and image analysis were all
performed as described previously [13,19,20].
RESULTS
Protease activity in calpain-1-null erythrocytes
We generated calpain-1-null mice by targeted mutagenesis of
the Capn1 gene [4]. Targeted deletion of eight amino acids
(residues 153–160) was introduced within exon 4 of the Capn1
gene, followed by the insertion of the gene-disrupting pGK-Neo
cassette. The calpain-1-null mice were backcrossed more than
20 generations on a C57BL/6 genetic background. Erythrocytes
isolated from adult mice were analysed for calpain activity.
Erythrocytes, free of platelets and leucocytes, were assayed
for total calpain activity by casein zymography. The calpain-
1-null erythrocytes were deficient of any detectable protease
activity by casein zymography (results not shown), consistent
with our previous findings using PCR and casein zymography
[4]. Similarly, purified erythrocyte membranes (ghosts) free of
haemoglobin were also completely deficient of any calpain
activity by casein zymography (results not shown). Since both
erythrocyte calpains migrate at the same position on SDS/PAGE
under reducing conditions, a monoclonal antibody that detects
both calpain-1 and calpain-2 enzymes with equal efficiency was
used. Western blotting did not detect any calpain-reactive band
in the calpain-1-null ghosts (results not shown). These results
demonstrate that no compensatory induction of calpain-2 occurs
in the adult calpain-1-null erythrocytes. Our results also indicate
that calpain-1 is the dominant cysteine protease in adult mouse
erythrocytes, since no protease activity was detected against the
denatured casein and erythrocyte membrane proteins as substrates
under these conditions.
Calpain-1-mediated proteolysis of erythrocyte membrane proteins
Using synthetic inhibitors of calpain activity, several attempts
have been made to identify the substrates of calpain-1 in
erythrocyte ghosts [21,22]. These studies identified multiple
substrates of calpain activity in erythrocyte ghosts, including
spectrin [21]. Similarly, using our calpain-1-null mice on a mixed
genetic background, we have shown that proteolysis of several
erythrocyte membrane proteins, including ankyrin, adducin, band
3, protein 4.1R and dematin, is inhibited in the calpain-1-null
erythrocytes [23]. To further investigate the effect of calpain-1
deficiency on spectrin proteolysis and phosphorylation, intact
erythrocytes were loaded with calcium via the calcium ionophore
A23187, and membrane proteins were analysed for degradation
and phosphorylation (Figure 1). It is to be noted that erythrocytes
were purposely loaded with high concentrations of calcium for
two reasons: (i) unlike human erythrocytes, we found that the
mouse erythrocyte membrane proteins were relatively resistant to
calcium-induced degradation under these conditions; and (ii) we
wanted to examine if other calcium-dependent proteases exist
that might be activated at high calcium concentrations, thus
compensating for calpain-1 loss in the calpain-1-null erythrocytes.
Since we did not detect any measurable proteolysis
of membrane proteins in WT erythrocytes loaded with 400 μM
calcium after 10 min of incubation at 37 ◦C (results reviewed but
not shown), proteolysis of membrane proteins was examined in
mouse erythrocytes loaded with 1.0 mM calcium (Figure 1A). No
proteolysis of membrane proteins was observed in the calpain-1-
null erythrocytes even at high calcium concentrations (Figure 1A).
It is to be noted that a relatively small reduction (∼15%)
of protein 4.1R in the calcium-treated KO (knockout) cells
could be attributed to transglutaminase-mediated cross-linking
of membrane proteins, which is independent of calpain-1 loss in
erythrocytes [23]. These findings indicate that calcium-dependent
protease activity is absent in the calpain-1-null erythrocytes under
these conditions. Interestingly, no degradation of spectrin was
observed in either WT or KO erythrocytes, even at high calcium
concentrations (Figures 1A and 1B). This observation was
confirmed by Western blotting using a polyclonal antibody against
spectrin (Figure 1C). In contrast, similar blotting experiments
confirmed ankyrin, adducin, band 3, protein 4.1R and dematin
as calpain-1 substrates, whereas protein 4.2 and actin were not
degraded under these conditions (results not shown).
It is well known that erythrocyte membrane proteins,
including β-spectrin, are phosphorylated by multiple protein
kinases in intact erythrocytes [24]. To examine the dependence
of protein kinase activity on calpain-1, particularly on
β-spectrin phosphorylation, intact erythrocytes were metabolic-
ally labelled with radiolabelled phosphate. Protein kinases were
activated with dibutyryl-cAMP, an activator of PKA (cAMP-
dependent protein kinase); PMA, an activator of PKC; and
calcium (500 μM) plus calcium ionophore A23187 (1.0 μM),
to activate calcium-dependent kinases as well as calpain-1.
Radiolabelled erythrocytes were incubated for 30 min at 37 ◦C,
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Figure 1 Proteolysis and phosphorylation of erythrocyte membrane proteins
(A) SDS/PAGE of erythrocyte ghosts [Coomassie Blue (CB): 50 μg of total protein] isolated from WT ( + / + ) and calpain-1-null ( − / − ) mice. Erythrocytes were treated with calcium ionophore
A23187 (1.0 μM) and CaCl2 (1.0 mM) at 37◦C for 10 min. The position of major membrane proteins is indicated. (B) SDS/PAGE of erythrocyte ghosts (50 μg of total protein) from WT ( + / + ) and
calpain-1-null ( − / − ) mice. Intact erythrocytes were metabolically labelled with [32P]Pi following stimulation with either 2.0 mM dibutyryl-cAMP or 1.0 μM PMA, or 1.0 μM A23187 plus 500 μM
CaCl2 for 30 min at 37◦C. The Coomassie Blue and autoradiogram (AT) panels of the same gel are shown. The position of major membrane proteins is indicated. (C) Western blot (WB) analysis
of spectrin in WT ( + / + ) and calpain-1-null ( − / − ) ghosts at 400 and 1000 μM calcium. This analysis was performed since ankyrin migrates under the β-spectrin band, thus complicating the
quantification of spectrin in the Coomassie-Blue-stained gels. No degradation of spectrin and p55/MPP1 was observed under these conditions. The lower panel shows the actin control for equal
loading of the membrane proteins. (D) Western blot analysis of PKC proteolysis in ghosts isolated from WT ( + / + ) and calpain-1-null ( − / − ) erythrocytes following activation either with 1.0 μM
PMA or 1.0 μM A23187 plus 500 μM CaCl2. The lower panel shows the actin control for equal loading of the membrane proteins.
and phosphorylation of membrane proteins was examined by
SDS/PAGE followed by autoradiography (Figure 1B). The loss
of calpain-1 did not affect the phosphorylation of β-spectrin and
other membrane proteins under these conditions (Figure 1B).
We noted that limited proteolysis of PKC occurred
in the unstimulated, calcium-activated and PMA-stimulated
WT erythrocytes, but not in the calpain-1-null erythrocytes
(Figure 1D). This observation is consistent with previous evidence
showing that PKC undergoes limited proteolysis by calpain to
generate an active membrane-associated form designated as PKM
(protein kinase M) [8,25]. The active PKM then phosphorylates
membrane proteins, thus modulating the membrane properties in
intact erythrocytes [24]. Surprisingly, all major phosphorylation
targets, including β-spectrin, band 3, protein 4.1R and dematin,
remained unaltered in the calpain-1-null erythrocytes (Figure 1B).
These observations suggest that the conversion of PKC into PKM
by calpain-1 is not required for regulating phosphorylation of
major membrane proteins in mouse erythrocytes under these
conditions.
Calpain-1 regulates erythrocyte shape change
On the basis of cysteine protease inhibitors, early evidence
suggested that calpain activity plays a regulatory role in the
transition of human erythrocyte shape from discocytes to
echinocytes [26]. We investigated this observation using WT
and calpain-1-null erythrocytes loaded with either low (50 μM)
or high (1.0 mM) Ca2 + in the presence of calcium ionophore
A23187 (1.5 μM). The erythrocyte shape, assessed by phase-
contrast microscopy, showed normal discocyte morphology in
both WT and KO erythrocytes under resting conditions (Figure 2).
Calcium-loaded erythrocytes were incubated at 37 ◦C, and cell
morphology was quantified at different time intervals (Figure 2).
Calpain-1-null erythrocytes loaded with 50 μM calcium were
significantly more susceptible to echinocyte and spheroechinocyte
shape transition as compared with the WT erythrocytes over
the 60 min incubation period (Figure 2A). When erythrocytes
were exposed to high calcium concentrations, the echinocyte
shape transition was again potentiated in the calpain-1-null
erythrocytes for up to 15 min of incubation as compared with WT
erythrocytes (Figure 2B, histogram). The number of echinocytes
began to decrease in the calpain-1-null samples after 15 min of
incubation with very few echinocytes detectable after 60 min
of incubation at 37 ◦C (Figure 2B, histogram). Consistent with
this observation, the number of spheroechinocytes significantly
increased in the calpain-1-null samples upon calcium loading over
the course of the 60 min incubation period (Figure 2, histograms).
Together, these observations suggest that the loss of calpain-1
modulates the erythrocyte shape transition from discocyte to
echinocyte/spheroechinocyte under these conditions.
Calpain-1 suppresses erythrocyte deformability and filterability
Since calpain-1 degrades key proteins of the erythrocyte
membrane skeleton, it was of interest to determine whether loss
of calpain-1 affects erythrocyte properties such as deformability
and filterability. To investigate this possibility, WT and KO
erythrocytes were incubated with calcium ionophore A23187
(1.0 μM) in calcium-free Tyrode’s buffer and loaded with
50 μM calcium for 10 min at 37 ◦C. Erythrocytes were then
subjected to increasing shear stress, and their deformability was
measured using the Rheoscan-D300 Ektacytometer (Figure 3A).
The maximum value of the deformability index, an approximate
measure of the erythrocyte membrane deformability at the
optimal surface to volume ratio, progressively increased with
the shear stress (Figure 3A). Importantly, the deformability
index was significantly higher in the calpain-1-null erythrocytes
as compared with WT erythrocytes (P < 0.02 for all values
shown in Figure 3A). As expected, the calcium loading caused
a precipitous decline in the erythrocyte deformability of both
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Figure 2 Calcium-induced erythrocyte shape change
(A) Erythrocytes from WT and calpain-1-null (KO) mice were treated with calcium ionophore A23187 (1.5 μM) and incubated with 50 μM CaCl2. After incubation at 37◦C for specified time intervals,
erythrocyte shape change was quantified by phase-contrast microscopy (bottom panels). (B) Same conditions as shown in (A), except the concentration of calcium was increased to 1000 μM.
Note that the echinocyte formation was potentiated in the absence of calpain-1 at both calcium concentrations; however, the kinetics of echinocyte and spheroechinocyte formation was differentially
regulated at higher calcium concentration. Scale bar, 10 μM.
genotypes (Figure 3A). Again, the deformability index was higher
in the calpain-1-null erythrocytes as compared with the WT mice
(Figure 3A).
To obtain a different measure of the impact of calpain-1 loss on
erythrocyte rheology, we measured the filterability of the erythro-
cytes through a 4.6 μm nickel mesh (Figure 3B). The filtration rate
of WT and KO erythrocytes was similar when both cell types were
analysed in the absence of calcium loading (Figure 3B). However,
following exposure to calcium ionophore A23187 and increasing
concentrations of calcium for 30 min at 37 ◦C, the filtration rate of
calpain-1-null erythrocytes was reproducibly higher as compared
with WT erythrocytes (Figure 3B). For example, at 500 μM
calcium, the mean filterability of the calpain-1-null erythrocytes
was 18% higher than the control erythrocytes, indicating that the
absence of calpain-1 protects the cells against a calcium-induced
decline in filtration rate. No erythrocyte lysis was observed under
these conditions.
Effect of calpain-1 loss on erythrocyte fragility, density and
lifespan
The effect of calcium influx on erythrocyte osmotic fragility
was examined at different salt concentrations (Figures 4A and
4B). Washed erythrocytes treated with 1.0 μM calcium ionophore
A23187 were loaded with 100 μM calcium for 15 min at 37 ◦C,
and cell lysis was measured by haemoglobin release [13].
Although calcium influx into erythrocytes did shift the fragility
curve in both genotypes, the statistical difference between the
haemolysis of WT and KO erythrocytes was not significant
(Figure 4A). However, in several osmotic fragility measurements,
we noticed that the extent of haemolysis was slightly higher in the
KO erythrocytes at a particular salt concentration. To investigate
this observation further, we compared the haemolysis profile of
freshly isolated erythrocytes with no exposure to ionophore and
calcium (Figure 4B). This step was taken to potentially eliminate
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Figure 3 Erythrocyte deformability and filterability analysis
(A) Measurement of erythrocyte deformability by Ektacytometry. Erythrocytes from WT and KO
mice were resuspended in calcium-free Tyrode’s buffer, and treated with calcium ionophore
A23187 (1.0 μM) and calcium (50 μM) as described in the Experimental section. Deformability
measurements were performed in a RheoScan D-300 instrument. (B) Measurement of the
erythrocyte filterability. WT and calpain-1-null (KO) erythrocytes were diluted to 0.1 %
haematocrit, and allowed to filter through a 4.6 μm pore nickel mesh filter. Data shown are
means +− S.D. for four to six measurements from two independent experiments. Further details
are given in the Experimental section.
the detrimental effects of the incubation period on erythrocyte
properties. Overall, the haemolysis pattern was similar between
the WT and KO erythrocytes at various salt concentrations
(Figure 4B). However, we consistently noticed a small increase in
the haemolysis of calpain-1-null erythrocytes at 200 m-osM salt
concentration as compared with WT erythrocytes (Figure 4B).
Next, we measured the effect of calpain-1 loss on erythrocyte
density using the oil-based microcapillary method as described
previously [27]. There was a relatively small but reproducible
shift towards the less dense and thus younger erythrocytes in
the calpain-1-null mice (Figure 4C). Finally, the in vivo
erythrocyte lifespan was determined by injecting NHS–biotin
through the tail vein, and the percentage of biotin-labelled
erythrocytes was measured by flow cytometry as described
previously [13]. There was no significant difference in the in vivo
half-life of calpain-1-null erythrocytes, as compared with WT
mice, over the course of 50 days (Figure 4D).
K+–Cl− co-transport is deregulated in calpain-1-null erythrocytes
The increased deformability and filterability properties of
calpain-1-null erythrocytes suggested potential deregulation in
the cellular volume regulatory pathways. To investigate the
possibility that calpain-1 gene deletion may induce changes
in K+ transport, we measured the activity of the Gardos
channel and KCC1, both of which are known to play critical
roles in the erythrocyte volume regulation. The activity of the
Gardos channel was significantly reduced in the calpain-1-null
erythrocytes as compared with WT mice (0.48 and 0.28 mmol/l
cell per min respectively; P < 0.03, n = 6). Similarly, the KCC1
activity was also reduced in the calpain-1-null erythrocytes
(WT = 1.55 +− 0.42, KO = 0.46 +− 0.16 mmol/1013 cell per h;
P < 0.04, n = 3) (Figure 5A). These results suggest that the
K+ transport pathways are deregulated in the calpain-1-null
erythrocytes under these conditions.
Calpain-1 differentially regulates erythrocyte calcium pump
Since the K+ transport pathways are known to be activated
by intracellular calcium, we surmised that the PMCA might
be deregulated in the calpain-1-null erythrocytes. To test this
possiblity, the PMCA activity was measured in the erythrocyte
membranes (ghosts) over a range of free calcium concentrations
(0–10 μM). The calcium pump activity was measured in
the presence of inhibitors of known ATPases, thus ensuring the
specificity of PMCA activity. The activity of the calcium pump
was measured both in the absence and presence of exogenous
CaM, a physiological regulator of the calcium pump [28].
The results indicated a linear increase in the pump activity
with increasing calcium concentrations followed by a plateau
(Figure 5B), consistent with earlier findings showing a Michaelis–
Menten type of enzyme kinetics [29]. The addition of CaM to the
PMCA assay resulted in the ∼2.5-fold stimulation of the basal
pump activity (Figure 5B), attesting to the ability of this calcium
sensor to serve as the physiological stimulator of PMCAs. There
was a significant reduction in the Vmax values of basal pump
activity in the calpain-1-null ghosts as compared with the WT
mice (Figure 5C). In contrast, the CaM-stimulated pump activity
was relatively higher in the calpain-1-null ghosts as compared
with the WT ghosts (Figure 5B). The reduction in basal activity
and elevation in CaM-stimulated PMCA activity in calpain-1
KO erythrocytes (Figures 5B and 5C) suggest the possibility of
the existence of a wider range of PMCA activity states in the
calpain-1 KO mice, which in turn would allow greater variability
in the levels of intracellular calcium levels in erythrocytes. The
differential effect on PMCA activity was obvious from the Vmax
values shown in Figure 5(C), which were calculated from the
curve fitting of the calcium curve data shown in Figure 5(B). The
calculated Vmax values in the WT and KO ghosts were 8.56 +− 0.31
and 4.07 +− 1.3 in the absence of CaM, and 20 +− 2.02 compared
with 22.9 +− 0.9 in the presence of CaM respectively (Figure 5C).
The difference in Vmax values between WT and KO in the absence
of CaM were statistically significant as determined by the Mann–
Whitney Rank Sum Test (P < 0.029).
To investigate the basis of lower basal activity of PMCAs
in the calpain-1-null ghosts (Figure 5C), the protein levels of
both PMCA1 and PMCA4 isoforms, the two isoforms present
in erythrocyte membranes, were examined by Western blotting.
There were no detectable differences in the protein profile of
PMCA isoforms between the WT and KO ghosts, suggesting that
the observed reduction in the PMCA activity in KO ghosts is not
mediated via altered PMCA protein levels, but may originate from
differences in the regulation of enzyme activity. Nonetheless, we
cannot rule out the possibility that subtle differences in the limited
cleavage of erythrocyte PMCAs may have been missed by the
Western blotting conditions used in the present study. Since
the CaM-stimulated PMCA activity was elevated in the calpain-
1-null ghosts (Figure 5C), a possibility exists that relatively less
CaM may be associated with the calcium pump in calpain-1-
null ghosts. To test this possibility, the amount of CaM was
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Figure 4 Erythrocyte osmotic fragility, density and lifespan measurements
(A) Washed erythrocytes from WT and calpain-1-null (KO) mice were subjected to the osmotic fragility test as described in the Experimental section. (B) Osmotic fragility of WT and KO erythrocytes
was performed using a narrow range of salt concentrations. (C) Density gradient separation of light (young) and dense (old) erythrocytes from WT and KO mice. (D) Determination of erythrocyte
lifespan in vivo. Flow cytometry was used to quantify the percentage of NHS–biotin-labelled erythrocytes as described in the Experimental section.
Figure 5 Measurement of KCC1 and calcium pump activity
(A) The K+–Cl− co-transport activity in the WT and calpain-1-null (KO) erythrocytes. The activity of KCC1 was measured as a volume-stimulated and Cl− -dependent component as described in the
Experimental section (P < 0.04, n = 3). The values are expressed as mmol/1013 cells per h, and represent the means +− S.E.M. for three independent samples performed in triplicate. (B) Effect of
increasing concentrations of free calcium on PMCA activity in the WT and KO ghosts in the absence and presence of 340 nM CaM (n = 4). (C) Calculated values of V max of PMCA activity in the WT
and KO ghosts (n = 4). (D) Immunoblot showing the level of CaM protein bound to WT and KO ghosts [50 μg of protein loaded on to SDS/PAGE (17 % gel), 1:500 dilution of anti-CaM antibody,
1:1000 dilution of anti-mouse secondary antibody (n = 3)]. Densitometric analysis of the CaM immunoblot (n = 3). PMCA was used as a control for equal loading of the membrane proteins.
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Table 1 AFM of mouse erythrocyte cytoskeleton
(i) WT erythrocytes
Parameter No treatment 50 μM calcium
Cytoskeleton height (nm) 7.06 6.96 6.75 7.89 7.72 7.65
Volume (×106) (nm3) 5.14 5.62 5.36 5.27 5.25 5.64
Grain size (×104) (nm2) 0.18 0.23 0.16 0.65 0.57 0.53
(ii) Calpain-1-null erythrocytes
Parameter No treatment 50 μM calcium
Cytoskeleton height (nm) 7.40 7.38 7.56 7.42 7.24 7.11
Volume (×106) (nm3) 5.35 5.11 5.28 5.27 5.02 5.98
Grain size (×104) (nm2) 0.29 0.45 0.41 0.39 0.34 0.48
quantified by Western blotting using an anti-CaM antibody in
erythrocyte ghosts normalized by their PMCA content. The results
from four independent experiments indicated a 17% reduction in
CaM bound to the calpain-1-null ghosts, a difference that was
statistically significant (P < 0.05) (Figure 5D). Taken together,
these results suggest that calpain-1 differentially regulates PMCA
activity and CaM content in mouse erythrocyte membranes under
these conditions.
AFM reveals a protective role of calpain-1 loss on erythrocyte
membrane skeleton
AFM topographic images of WT erythrocyte membrane revealed
an intact cytoskeleton network with fine filament structure
(Figure 6) similar to the previously reported results [13,19,20].
Influx of 50 μM calcium in erythrocytes via calcium ionophore
A23187 caused damage to the cytoskeleton integrity as evident by
the absence of fine structure and elevated cytoskeleton height and
grain size (Figure 6 and Table 1). AFM images of calcium-treated
calpain-1-null erythrocytes also showed loss of fine structure,
but the changes in the cytoskeleton height and grain size were
much less pronounced than those observed in the calcium-
treated WT controls (Figure 6 and Table 1). Consistent with the
erythrocyte deformability data (Figure 3A), the loss of calpain-1
provided protection from the calcium-induced cytoskeleton
instability as 50 μM calcium influx did not produce any significant
change in the cytoskeleton height and grain size (Table 1).
These results suggest that the loss of calpain-1 only slightly
modifies the cytoskeletal network under steady-state conditions,
and offers significant protection under conditions of calcium-
induced calpain-1 activation in intact erythrocytes.
DISCUSSION
Since the discovery of the calpain system almost 50 years ago
[30], the calcium-dependent neutral protease family has attracted
considerable attention because of its involvement in numerous
physiological processes [1,2,31]. There are 14 independent
genes that encode calpain-related proteins; however, the term
calpain activity generally refers to the cumulative activity of
two calpains. Calpain-1 is activated at micromolar calcium
concentrations, whereas calpain-2 is activated at millimolar
calcium concentrations in vitro. Both calpains show overlapping
substrate specificity, and are expressed in most mammalian cells.
An exception is the adult erythrocyte, where the total calpain
activity is contributed exclusively by calpain-1 [4]. Using calpain-
1-null mice (KO) previously generated in our laboratory [4],
in the present study we investigated the physiological function
of calpain-1 in adult erythrocytes. Mature erythrocytes harvested
from mice with a C57BL/6 genetic background were examined by
casein zymography and Western blotting. As expected, no calpain
polypeptide or activity was detected in the KO erythrocytes,
consistent with our previous findings [4]. Thus generation of
calpain-1-null mice with no gross haematological abnormality set
the stage for interrogating the biological function of erythrocyte
calpain-1 both in vitro and in vivo.
Our previous studies have shown that ankyrin, band 3, protein
4.1R, adducin and dematin are degraded in calcium-activated
WT but not KO erythrocytes [23]. Similarly, the transglutaminase
TG2 activity remained unaffected in calpain-1-null erythrocytes
[23]. In the present study, the same set of erythrocyte membrane
proteins was found to be resistant to calcium-induced degradation
in calpain-1-null mice on a pure genetic background (Figure 1A).
This finding is consistent with the previous identification of
multiple substrates by direct binding of calpain to the erythrocyte
membrane vesicles [32]. However, an unresolved issue remains
with the identification of spectrin as a physiological substrate of
calpain-1 in erythrocytes. For example, it has been shown that
erythrocyte spectrin is degraded by calpain-1 in vitro [21,26].
In contrast, our results indicate that spectrin is not degraded
in calcium-loaded erythrocytes either in the WT or KO mice
(Figure 1). In our opinion, degradation of ankyrin that migrates
under the spectrin band may account for this discrepancy.
Alternatively, species differences, the concentration of calcium
ionophores and incubation conditions are some of the other
possibilities that could explain these apparently contradicting
findings. Nonetheless, calpain-1 is likely to degrade non-erythroid
spectrins, such as the brain fodrin, upon calcium activation. These
models will now be testable in the calpain-1-null mice with a
defined genetic background.
Several studies have shown that calpain-1 causes limited
cleavage of PKC to generate PKM, whose biological function re-
mains poorly defined [33,34]. One view supports the notion
that limited proteolysis of PKC results in its constitutive
activation, and the resultant PKM phosphorylates downstream
targets in erythrocytes [8]. For example, treatment of erythrocytes
with calpain inhibitors blocked PKC-mediated phosphorylation
of protein 4.1R and protein 4.9 (dematin) with concomitant
suppression of PKM [8]. An alternative model predicted that
generation of PKM initiates the final degradation pathway of
PKC, thus eventually depleting the enzyme [35]. Our results
suggest that calpain-1 cleavage of PKC is not necessary for the
phosphorylation of erythrocyte membrane proteins, irrespective
of whether erythrocytes are stimulated by cAMP, PMA or calcium
(Figure 1B). PKC serves as a substrate of calpain-1 since its
degradation is inhibited in calpain-1-null erythrocytes activated by
either calcium or PMA (Figure 1D). Moreover, phosphorylation of
β-spectrin and other substrates remained unaltered despite partial
degradation of PKC in normal erythrocytes (Figure 1B). These
results suggest that spectrin degradation and phosphorylation are
not regulated by calpain-1 in mouse erythrocytes under these
conditions.
Previous evidence indicated a functional role of calpain-1 in
the regulation of erythrocyte shape change [26]. Treatment of
erythrocytes with a calpain inhibitor blocked their transition from
echinocytes to spherocytes [26]. Similarly, purified cytoplasmic
domain of band 3 is known to inhibit erythrocyte membrane
shape change in vitro [36]. Our results from the present study
indicate that calpain-1 functions as a key regulator of erythrocyte
shape change (Figure 2). Moreover, our findings unveil some
new aspects of erythrocyte shape regulation by calpain-1.
The calpain-1 loss not only modulates the final erythrocyte
shape change, but also affects the rate of shape transition in
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Figure 6 AFM of mouse erythrocyte skeleton
Washed erythrocytes in PBS were treated with calcium ionophore A23187 and 50 μM calcium, attached on to the glass coverslips, lysed to expose the intracellular surface of the cytoskeleton, and
imaged using AFM essentially as described previously [13,19,20]. Images of WT erythrocyte cytoskeleton reveal an intact cytoskeleton network with fine filament structures similar to the results
previously reported [13,19,20]. Treatment of WT erythrocytes with calcium resulted in the damage of the cytoskeleton integrity as evident by diminished fine structures and increased aggregates. AFM
images of the calpain-1-null (KO) erythrocyte cytoskeleton show a similar loss of the fine structures (arrowheads) but fewer aggregates (arrows) were observed as compared with calcium-treated WT
controls, suggesting that the calpain-1 loss may only slightly modify the cytoskeleton. No detectable structural changes were observed in the KO cytoskeleton upon calcium treatment of erythrocytes
as compared with KO control cells, suggesting that calpain-1 loss protects erythrocytes from the calcium-induced cytoskeleton instability.
a calcium-dependent manner (Figure 2). In contrast with the
previous study [26], the discocyte to echinocyte shape transition is
potentiated in calpain-1 KO at a lower calcium concentration
(Figure 2A). At higher calcium concentrations, the rate of
discocyte–echinocyte transition was further augmented, thus
rapidly generating the end-stage spherocytes (Figure 2B). These
findings suggest that degradation of ankyrin, band 3, protein
4.1R and dematin by calpain-1 negatively regulates erythrocyte
shape change, whereas spectrin degradation and phosphorylation
are not necessary for this regulation under these conditions.
Previously, we have shown that calpain-1 loss does not affect
the phospholipid asymmetry, particularly erythrocyte surface
exposure of phosphatidylserine [37]. Taken together, our findings
offer an alternative model for the long-held view that the lipid
bilayer serves as a dominant regulatory site for erythrocyte
discocyte–echinocyte shape transition in vivo [38].
The shape and mechanical properties of erythrocytes are
thought to be partially controlled by the submembrane
network referred to as the membrane skeleton. Regulatory
modifications of skeletal proteins, such as oxidation, proteolysis
and phosphorylation have been known to influence the
mechanical properties of erythrocytes by altering critical protein
interactions. Because the calcium-induced phosphorylation of
membrane proteins remains normal in calpain-1-null erythrocytes
(Figure 1B), the KO model allowed us to directly evaluate the
impact of moderate skeletal protein proteolysis on erythrocyte
mechanical properties without complications arising from
differences in protein phosphorylation. Our results provide the
first evidence that inhibition of calcium-induced proteolysis
of skeletal proteins in intact erythrocytes offers significant
improvement in cell deformability and filtration rate (Figure 3).
It is conceivable that one or more of the calpain-1 substrates
in the erythrocyte membrane must remain intact to assure
maximal deformability and filtration through pores smaller than
the erythrocyte diameter.
The inhibition of erythrocyte skeletal protein degradation
in calpain-1-null mice does not influence their lifespan
in vivo under resting conditions (Figure 4D). Similarly, other
haematological parameters, such as bilirubin, iron, haem and
lactate dehydrogenase were unaffected in the KO mice (results
not shown). The reticulocyte count was also normal in calpain-1-
null mice. To reconcile subtle hydration phenotype in
calpain-1-null erythrocytes (Figure 4B), we measured erythrocyte
MCV (mean cell volume) in six adult mice of each genotype.
A small but statistically significant increase in the MCV of
KO erythrocyes was found (Table 2). Mechanistically, partial
inhibition of the Gardos channel and KCC1 (Figure 5A),
and an increase in the intracellular magnesium concentration
(Table 2), could potentially contribute to modest MCV increase
in KO erythrocytes, since these systems are known to play
a functional role in erythrocyte volume regulation [16,39,40].
Alternatively, calpain-1 loss may trigger down-regulation of as
yet unknown membrane-associated protein phosphatases, thus
causing inhibition of the KCC1 [41,42]. Some of these models
will be testable in the calpain-1-null mice described in the present
study.
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Table 2 Comparison of calpain-1-null with WT erythrocytes
Values are means + S.E.M. (n = 6). MCHC, mean corpuscular haemoglobin concentration.
Total intracellular ion concentration, mmol/kg of haemoglobin.
Parameter WT erythrocytes Calpain-1-null erythrocytes P value
MCV (fl) 47.20 +− 0.92 49.50 +− 0.48 0.0298
Haematocrit (%) 35.88 +− 1.56 42.90 +− 3.06 0.0390
Haemoglobin (g/dl) 11.28 +− 0.39 13.58 +− 0.89 0.0252
MCHC (%) 32.44 +− 0.43 31.80 +− 0.35 0.1398
[Na+ ]i 4.58 +− 0.11 3.48 +− 0.16 0.0002
[K+ ]i 123.80 +− 4.12 116.22 +− 5.01 0.1350
[Mg2 + ]i 8.05 +− 0.14 8.92 +− 0.21 0.0027
Calcium influx exerts pleiotropic effects on multiple pathways
in erythrocytes, including membrane ion transport. One of the key
determinants of intracellular calcium is the integral membrane
protein referred to as calcium pump or PMCA [6,43,44].
The PMCA utilizes metabolic energy from ATP hydrolysis to
transport Ca2 + across the plasma membrane against a 10000-
fold gradient, thus playing a critical role in maintaining precise
levels of intracellular calcium. The PMCA is a ∼140 kDa
protein with ten transmembrane helices and several intracellular
domains, including its active site located between transmembrane
segments 4 and 5. The C-terminal end of the PMCA contains
an autoinhibitory domain, which interacts with its catalytic site,
preventing the binding and utilization of ATP, thus keeping the
enzyme in a state of low activity [45]. Binding of CaM, a
calcium-binding protein, to PMCA triggers the dissociation of
the autoinhibitory domain away from the catalytic core and release
of autoinhibition, thus stimulating PMCA activity several-fold
and providing the driving force for Ca2 + transport across the
plasma membrane [45–48]. As shown in Figure 5, differential
regulation of PMCA activity and CaM content in calpain-1-null
erythrocytes may offer a potential mechanistic explanation for the
regulation of erythrocyte cell shape, deformability, filterability
and MCV. Since excessive calcium influx is a hallmark of several
erythrocyte diseases, including sickle cell anaemia [39,49,50],
our findings raise the possibility that pharmacological inhibition
of calpain-1 may offer a therapeutic option against sickle cell
disease and other calcium-related pathologies.
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